Alkem’s Manufacturing Facility At Baddi Receives 2 Observations From USFDA

The US FDA had conducted an inspection at Alkem Laboratories Limited’s manufacturing facility located at Baddi, India from 17th February, 2020 to 21st February, 2020.

At the end of inspection, the Company has received a Form 483 with two (2) observations. The Company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA observations and the same is proposed to be filed within the timeline stipulated by US FDA.

Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.2657.75 as compared to the previous close of Rs. 2621.25. The total number of shares traded during the day was 2566 in over 365 trades.

The stock hit an intraday high of Rs. 2690 and intraday low of 2627. The net turnover during the day was Rs. 6837074.-Equity Bulls